Organon & Company Aktie
| 8,11USD | 0,58USD | 7,71% |
WKN DE: A3CPKP / ISIN: US68622V1061
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 9 300 | 10 000 | 10 000 | 10 000 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,68 | 0,62 | 0,63 | 0,64 | 0,00 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 3 760 | 3 931 | 4 508 | 4 348 | 0 |
| Summe Anlagevermögen | 6 921 | 7 024 | 7 550 | 8 753 | 0 |
| Summe Aktiva | 10 681 | 10 955 | 12 058 | 13 101 | 0 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 12 189 | 11 847 | 12 128 | 12 629 | 0 |
| Summe Eigenkapital | -1 508 | -892 | -70 | 472 | 0 |
| Summe Passiva | 10 681 | 10 955 | 12 058 | 13 101 | 0 |
Adresse
| 30 Hudson Street, 07302 Jersey City | |
| Telefon | +1 (551) 430-6900 |
| Internet | http://www.organon.com |
Management
|
Aaron Falcione
Chief Human Resources Officer |
|
Carrie Smith Cox
Executive Chairman |
|
Charlotte Owens
Head-Medical Affairs & Outcomes Research |
|
Cynthia M. Patton
Independent Director |
|
Daniel Karp
Executive Vice President-Corporate Development |
|
Deborah R. Leone
Independent Director |
|
Grace Puma Whiteford
Independent Director |
|
Helene D. Gayle
Independent Director |
|
Jennifer Halchak
Head-Investor Relations |
|
Joseph T. Morrissey
Chief Executive Officer & Executive Vice President |
|
Juan Camilo Arjona Ferreira
Chief Medical Officer & Head- R&D |
|
Julie Pentz
Chief Procurement Officer |
|
Kathryn DiMarco
Senior Vice President-Finance & Controller |
|
Kirke Weaver
Secretary, Executive VP & General Counsel |
|
Matthew M. Walsh
Chief Financial Officer & Executive Vice President |
|
Michael Pergine
Head-Commercial & Government Affairs |
|
Philip O. Ozuah
Independent Director |
|
R. Alan B. Ezekowitz
Independent Director |
|
Rachel A. Stahler
Chief Digital & Commercial Innovation Officer |
|
Ramona Sequeira
Director |
|
Robert A. Essner
Lead Independent Director |
|
Rochelle B. Lazarus
Independent Director |
|
Shalini Sharp
Independent Director |
|
Susan O'Neal
Chief Ethics & Compliance Officer |
|
Tom Merriam
Chief of Staff & Head-Corporate Strategy |
|
Vittorio Nisita
Executive VP & Head-Global Business Services |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.